HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Massard, G. Articles by Morand, G. Search for Related Content PubMed PubMed Citation Articles by Massard, G. Articles by Morand, G.

European Journal of Cardio-Thoracic Surgery, Vol 10, 397-402, Copyright © 1996 by European Association for Cardio-thoracic Surgery

ARTICLES

Association of bronchial and pharyngo-laryngeal malignancies. A reappraisal

G Massard, JM Wihlm, S Ameur, GM Jung, C Rouge, P Dumont, N Roeslin and G Morand
Department of Thoracic Surgery, University Hospital of Strasbourg, France.

OBJECTIVE: The purpose of this study was to re-evaluate operative risk and probability for survival patients with a history of upper aerodigestive cancer, who underwent thoracotomy for presumed primary bronchogenic cancer. Our hypothesis was to consider any isolated lung opacity as a primary bronchogenic cancer. METHODS: The cohort under investigation included 114 consecutive patients. Histology of bronchial cancer was squamous cell carcinoma in 98 patients (86%), adenocarcinoma in 14 (12%) and large cell carcinoma in 2 (2%). Exploratory thoracotomy was performed in 5 patients (4%); the remaining 109 patients underwent a potentially curative resection, including 25 pneumonectomies (22%) and 84 conservative resections (74%). Pathological staging was as follows: 66 stage I (58%), 20 II (17.5%), 20 IIIa (17.5%), 6 stage IIIb (5%), and 2 stage IV (2%). RESULTS: Four patients died post-operatively (3.5%). Non-fatal morbidity concerned 32 patients (28.1%) and was dominated by respiratory superinfections. Incidence of respiratory infections was increased after voice-sparing resections (chi 2 = 4.311, P < 0.05), and more particularly after transmaxillary buccopharyngectomy (chi 2 = 12.224; P < 0.01). Estimated 5-year survival was 28.7% (33.3% in stage I, 19.2% in stage II, and 30.2% in stage III). There was no difference in survival with reference to the location of head and neck cancer (chi 2 = 3.412; 0.05 < P < 0.1) or chronology (chi 2 = 0.005; P > 0.9). CONCLUSIONS: We conclude that isolated lung opacities in patients with previous or simultaneous head and neck cancer are most likely primary bronchogenic cancers. The acceptable operative mortality legitimizes surgical treatment despite an impaired 5-year survival; patients with a previous voice-sparing operation are at increased risk for respiratory complications and should be managed carefully.

This article has been cited by other articles:

				M. Filaire, T. Mom, S. Laurent, Y. Harouna, A. Naamee, L. Vallet, B. Normand, and G. Escande Vocal cord dysfunction after left lung resection for cancer Eur. J. Cardiothorac. Surg., October 1, 2001; 20(4): 705 - 711. [Abstract] [Full Text] [PDF]

				T. Mom, M. Filaire, D. Advenier, C. Guichard, A. Naamee, G. Escande, X. Llompart, L. Vallet, J. Gabrillargues, C. Courtalhiac, et al. Concomitant type I thyroplasty and thoracic operations for lung cancer: Preventing respiratory complications associated with vagus or recurrent laryngeal nerve injury J. Thorac. Cardiovasc. Surg., April 1, 2001; 121(4): 642 - 648. [Abstract] [Full Text] [PDF]

				G. Massard, X. Ducrocq, M. Beaufigeau, S. Elia, R. Kessler, J.-F. Herve, and J.-M. Wihlm Lung cancer following previous extrapulmonary malignancy Eur. J. Cardiothorac. Surg., November 1, 2000; 18(5): 524 - 528. [Abstract] [Full Text] [PDF]

				B. G. Bentz and C. H. Snyderman Pulmonary Complications in Patients With Head and Neck and Lung Neoplasms Arch Otolaryngol Head Neck Surg, March 1, 2000; 126(3): 429 - 432. [Abstract] [Full Text] [PDF]

				G. Massard, R. Kessler, B. Gasser, X. Ducrocq, S. Elia, S. Gouzou, and J.-M. Wihlm Local control of disease and survival following bronchoplastic lobectomy for non-small cell lung cancer Eur. J. Cardiothorac. Surg., September 1, 1999; 16(3): 276 - 282. [Abstract] [Full Text] [PDF]